The splicing factor SF3B1 is the most commonly mutated gene in the myelodysplastic syndrome (MDS), particularly in patients with refractory anemia with ring sideroblasts (RARS). This evidence concerns the gene SF3B1 and myelodysplastic syndrome with ring sideroblasts.